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Background: NDE1 and NDEL1 are neurodevelopmental and mitotic proteins with extended coiled-coil N termini, but
unknown C-terminal structure.
Results: Recombinant NDE1/NDEL1 form dimers and tetramers in which their C termini interact with their N-terminal
domains.
Conclusion: NDE1/NDEL1 each adopt a sharply bent back structure.
Significance: This explains the existence of two distinct dynein-binding domains on NDE1/NDEL1 and instability of disease-
associated mutants lacking C termini.
Paralogs NDE1 (nuclear distribution element 1) and NDEL1
(NDE-like 1) are essential for mitosis and neurodevelopment.
Both proteins are predicted to have similar structures, based
uponhigh sequence similarity, and they co-complex inmamma-
lian cells. X-ray diffraction studies and homologymodeling sug-
gest that their N-terminal regions (residues 8–167) adopt con-
tinuous, extended -helical coiled-coil structures, but no
experimentally derived information on the structure of their
C-terminal regions or the architecture of the full-length pro-
teins is available. In the case ofNDE1, no biophysical data exists.
Here we characterize the structural architecture of both full-
length proteins utilizing negative stain electron microscopy
along with our established paradigm of chemical cross-linking
followed by tryptic digestion, mass spectrometry, and database
searching, which we enhance using isotope labeling for mixed
NDE1-NDEL1. We determined that full-length NDE1 forms
needle-like dimers and tetramers in solution, similar to crystal
structures of NDEL1, as well as chain-like end-to-end polymers.
TheC-terminal domainof eachprotein, required for interaction
with key protein partners dynein and DISC1 (disrupted-in-
schizophrenia 1), includes a predicted disordered region that
allows a bent back structure. This facilitates interaction of the
C-terminal region with the N-terminal coiled-coil domain and
is in agreement with previous results showing N- and C-termi-
nal regions of NDEL1 and NDE1 cooperating in dynein interac-
tion. It sheds light on recently identifiedmutations in theNDE1
gene that cause truncation of the encoded protein. Additionally,
analysis of mixed NDE1-NDEL1 complexes demonstrates that
NDE1 and NDEL1 can interact directly.
NDE1 (nuclear distribution factor E-homolog 1, or nuclear
distribution element 1) and NDEL1 (NDE1-like 1) are highly
similar proteins, originating from a common ancestral gene (1,
2). Through their interactions with LIS1 (Lissencephaly 1,
encoded by PAFAH1B1) and dynein they play crucial roles in
microtubule organization and are required for cell cycle pro-
gression and neuronal development (reviewed in Ref. 3). They
have recently been implicated in the pathology of major mental
illness (reviewed in Ref. 4).
NDE1 (335 amino acid residues) andNDEL1 (345 amino acid
residues) both consist of distinct N- and C-terminal regions
(Fig. 1, A and B). X-ray crystallography, backed by other bio-
physical techniques, revealed how the N-terminal region of
NDEL1 dimerizes by forming extended, continuous parallel
-helical coiled-coils that account for approximately half the
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FIGURE 1. Sequence and structure of NDE1 andNDEL1. A, sequence alignment between NDE1 and NDEL1. Indicated above the alignment is the consensus
coiled-coil domain and predicted C-terminal -helix for the two proteins (shown schematically in B). Phosphorylation sites for NDE1 and NDEL1 are shown as
black and gray stars, respectively. NDE1microcephaly frameshift mutations are shown as filled triangles. Binding sites described in text for dynein, DISC1, and
LIS1 are indicatedbydashed linesbelowalignment. Prolines lyingbetweencoiled-coil regionandC-terminal-helix aredenotedby filledovals. Apalmytolation
site is indicated by a filled rectangle. B, NDE1 and NDEL1 have an N-terminal coiled-coil domain (longer gray cylinder), which is made up of three coiled-coil
regions (CC R): CC R1, CC R2, and CC R3. The two proteins are predicted to have a disordered C terminus (gray lines) containing a strongly predicted -helix
(shorter gray cylinder). The N and C termini are indicated. C, the NDEL1 N-terminal region was shown by crystallography (Protein Data Bank code 2V71) to
dimerize via a parallel coiled-coil utilizing CC R1 (amino acids 9–44) and CC R2 (amino acids 44–99) (5). The structure of the C terminus remains unsolved.
D, previously favored model of tetrameric assembly of full-length NDE1/NDEL1 (18) and, below, a structure determined by crystallography (the shorter
tetramer fragment, consisting of amino acids 58–168 of Protein Data Bank code 2V66 and the longer tetramer fragment, consisting of amino acids 8–167
derived using symmetry operations from Protein Data Bank code 2V71). In the crystal structures, two NDEL1 dimers associate using CC R3 (amino acids
107–167) in an anti-parallel arrangement, to form tetramers (5).
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length of the protein (residues 8–167) (Fig. 1C) (5, 6). Within
this region lie sites that interact with LIS1 (7, 8). Two NDEL1
dimers associate in an anti-parallel fashion to form four-helix
coiled-coil tetramers (Fig. 1D) (5). With 71% sequence
identity, the NDE1 N-terminal region is likely to form similar
structures (9). The C-terminal portions of both proteins are
known to harbor numerous phosphorylation sites (7, 10–12)
(Fig. 1A). These C-terminal regions are predicted to be largely
unstructured, with the exception of a single strongly predicted
-helix (11) (Fig. 1A). This predicted -helix in NDEL1 is
responsible for interaction with its key binding partner DISC1
(disrupted-in-schizophrenia 1) (13), as well as, potentially,
dynein and dynactin (14, 15). Frameshift mutations that lead to
a loss of this C-terminal region in NDE1 are known to cause
severe microcephaly (16, 17).
Current understanding of the structures of NDE1 and
NDEL1 is insufficient to explain important observations made
in the recent literature. Notably, each of NDEL1 and NDE1
possess two distinct regions at their N and C termini that
interact with intermediate chains of dynein (18, 19). Thus,
despite being separated by150 amino acids residues in the
primary structure, these two regions could be juxtaposed
because of the overall architecture of the folded protein.
Given that the disordered C-terminal regions are unlikely to
make good targets for crystallization, we have combined
negative stain EM with a strategy of chemical cross-linking,
MS, and database searching (6, 20, 21) to gain structural
insight into full-length NDE1 and NDEL1 molecules in solu-
tion. This extends a previous application of the cross-link-
ing/MS methodology to a truncated fragment of NDEL1 (6).
We found that the C-terminal region of each protein bends
back on to the main coiled-coil domain; this observation
sheds light on the molecular architecture of the complex
between NDE1, NDEL1, and dynein that is crucial for mito-
sis and neurodevelopment.
EXPERIMENTAL PROCEDURES
Primer Sequences and Cloning—Constructs encoding
V5-tagged NDE1 and NDEL1 have been described previously
(22). Open reading frames from these were subcloned in a two-
step PCR process that introduced an N-terminal His6 tag. The
primers usedwere: CCGAAAACCTGTATTTTCAGGGCGA-
GGACTCCGGAAAGACTTTCAG (NDE1, first step 5), GG-
GGCCGAAAACCTGTATTTTCAGGGCGATGGTGAAG-
ATATACCAG (NDEL1, first step 5), GGGGACCACTTTGT-
ACAAGAAAGCTGGGTCCTAGCAGGAGCTGGACGAC-
CTGGTTG (NDE1, both steps, 3), GGGGACCACTTTGTA-
CAAGAAAGCTGGGTCCTACACACTGAGAGGCAGCAT-




NDEL1, second step 5). The clones were sequentially
transferred first into the pDONR-221 entry vector and then
into pDEST-14 destination vector using BP clonase and LR clo-
nase (Invitrogen). Correct cloning and insertion was confirmed
by sequencing.
Protein Expression and Purification—To generate recombi-
nant NDE1 or NDEL1 constructs were transformed into C41
(DE3) cells (Lucigen Corporation, Middleton, WI) and grown
in either LB (NDE1) or 2TY (NDEL1)mediumcontaining 100
g/ml carbenicillin to A600 of0.6. Recombinant protein pro-
duction was induced by adding 1 mM IPTG and incubating at
30 °C for 3 h with shaking at 250 rpm.
To label NDE1 by stable isotope labeling by amino acids in
cell culture (SILAC)6 (23) for co-purification experiment with
unlabeled NDEL1, constructs were transformed into BL21
(DE3) LysA ArgA cells (24) and grown inM9minimal medium
(6 mg/ml Na2HPO4, 3 mg/ml KH2PO4, 1 mg/ml NH4Cl, 500
g/ml NaCl, 200 g/ml glucose, 50 ng/ml vitamin B1, 6 ng/ml
CaCl2, 1mMMgSO4) containing 100g/ml carbenicillin and 10
g/ml each of L-lysine and L-arginine that were 99% enriched
for the stable isotopes 13C and 15N (CK Gas Products). The
labeled NDE1 culture was induced as above and grown at 30 °C
for 3 h.
Bacterial pellets were extracted, resuspended in 30 ml of
immobilized metal affinity chromatography buffer (25 mM
sodiumphosphate, 500mMNaCl, 20mM imidazole, 1mMDTT,
pH 7.4) plus Complete protease inhibitor mixture (Roche
Applied Science) per liter of original culture and lysed using a
TS Cell Disruptor (Constant Systems) at 172 MPa. The lysates
were centrifuged at 50,000 g for 1 h, and the resultant super-
natants were passed through 0.2-m Whatman cellulose
nitrate membrane filters. The filtered supernatant was then
loaded onto a 1-ml HisTrap HP column (GE Healthcare),
charged with 1 ml of 100 mM nickel chloride, using an ÄKTA-
purifier (GE Healthcare). Bound proteins were eluted using
immobilized metal affinity chromatography buffer containing
an imidazole gradient rising from 20 to 500mM over 20 column
volumes.
Fractions containing recombinant NDE1 or NDEL1-sized
bands (confirmed by SDS-PAGE) were further purified by size
exclusion chromatography using a 320-ml HiLoad 26/60
Superdex 200 preparative grade column (GE Healthcare) and
PBS, pH 7.4 (for cross-linking analysis), or 25 mM HEPES, 200
mM NaCl, pH 7.4 (for electron microscopy analysis). Where
appropriate, protein fractions were concentrated using Vivas-
pin Concentrators (Sartorius Stedim Biotech). For each recom-
binant protein, identity was confirmed by MALDI-TOF mass
spectrometry (Applied Biosystems).
Biophysical Characterization—The mean hydrodynamic
radii of the purified proteins were determined by dynamic light
scattering using aZetasizer auto plate sampler (Malvern Instru-
ments Ltd.) at 10 °C with a 830-nm laser. Each dynamic light
scattering measurement was performed on protein solution
that was initially centrifuged for 15 min at 13,000 rpm.
For determination of secondary structure, protein was buf-
fer-exchanged into 10 mM sodium phosphate buffer, pH 7.4,
using pre-equilibrated PD-10 columns (GE Healthcare). Pro-
tein concentration was determined using a V-550 UV-visible
6 The abbreviations used are: SILAC, stable isotope labeling by amino acids in
cell culture; BS3, bis(sulfosuccinimidyl)suberate; CC R, Coiled-coil region;
CD, circular dichroism; MWt, molecular weight.
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spectrophotometer (JASCO) based on absorbance at 280 nm
and the theoretical extinction coefficient of the respective pro-
tein sequence. Circular dichroism (CD) analysis was performed
on a J-810 Spectropolarimeter (JASCO) at 25 °C using a path
length of 1 mm, over the far UV range 185–280 nm. Five scans
were acquired and averaged for each CD spectrum using the
following parameters: data pitch, 0.1 nm; bandwidth, 1 nm;
scan speed, 10 nm/min; and response time, 2 s). Solvent correc-
tion was achieved by subtraction of a spectrum of the buffer
solution acquired with identical parameters.
Chemical Cross-linking andMass Spectrometry—Cross-link-
ing experiments were carried out using bis(sulfosuccinimi-
dyl)suberate (BS3) (Thermo Fisher Scientific) as cross-linker in
a 1:1000 protein:BS3 molar ratio by incubating for 2 h on ice.
The reactions were quenched by the addition of 2.73 M ammo-
nium bicarbonate in a 10:1molar ratio with BS3 and incubation
on ice for a further hour. The proteins were separated by SDS-
PAGE, and bands corresponding to cross-linked complexes
were excised, and the proteins therein were reduced using 100
mMDTT for 30min at room temperature, alkylatedwith 55mM
iodoacetamide for 30min in the dark at room temperature, and
digested using 12.5 ng/l trypsin (sequencing grade; Promega)
overnight at 37 °C (6).
The supernatant containing the cross-linked peptides were
fractionated on SCX-StageTips (25), desalted using C18-Stage-
Tips (26), and analyzed on either an LTQ Orbitrap mass spec-
trometer (Thermo Fisher Scientific) or an LTQOrbitrap Velos
mass spectrometer (ThermoFisher Scientific) as described pre-
viously (20, 27). The peptides were analyzed using a high/high
strategy; bothMS spectra andMS-MS spectra were acquired in
the Orbitrap (20). The data were processed, generating peak
lists by MaxQuant (28) and matching cross-linked peptides to
spectra using in-house developed Xi software.
Homology Modeling—Modeling of the NDE1-NDEL1 het-
erotetramer was undertaken using Modeller version 9.10 (29)
based on the template fragments of NDEL1 solved by crystal-
lography (5) deposited in the ProteinData Bank, i.e., the shorter
fragment (regions 58–168) (Protein Data Bank code 2V66,
chains B–E) and the longer (regions 8–167) fragment (Protein
Data Bank code 2V71, chains A and B). Two heterotetramer
NDE1-NDEL1 models were built based on the (shorter)
tetramer and the (longer) tetramer sequence generated by sym-
metry operations, as described previously (9). Two sequences
each forNDE1 andNDEL1were aligned appropriately (Fig. 1A)
with the template NDEL1 sequences (2V66 and 2V71) to form
an anti-parallel arrangement. Thirty models were generated
corresponding to each of the alignments, and the ones with the
lowest objective function score (29) were selected as the repre-
sentative NDE1-NDEL1 model in each case. The models were
checked for valid stereochemistry using PROCHECK (30) and
additionally assessed for valid packing quality using WHAT IF
(31).
Negative Stain ElectronMicroscopy—NDE1 andNDEL1 pro-
tein samples were diluted to between 3 and 18 g/ml before
being placed on thin continuous carbon film electron micros-
copy grids and stainedwith 2% (w/v) uranyl acetate solution. To
rule out DNA contamination for observation of highmolecular
weight species, NDE1 and NDEL1 protein (0.15 mg/ml) were
independently incubated for 1 h at 37 ºC with 1.3 Kunitz units
of DNAse1 (Sigma) in a buffer containing 20 mM MgCl2 and
then diluted to 10g/ml protein immediately before being pre-
pared for EM (as above). The grids were imaged in low dose
mode using a F20 electron microscope (FEI, Eindhoven, The
Netherlands) fitted with an 8192 8192 digital camera (F816;
TVIPSGmbH, Germany). The images were collected at a nom-
inal magnification of 29,000 at 200 kV (the calibrated scale is
0.269 nm/pixel). The data were collected only in thinly stained
areas tomaximize the contrast from the particles. The particles
were manually selected (705 for NDE1 and 1299 for NDEL1),
normalized, and band pass-filtered before being input into an
iterative reference-free alignment and classification algorithm
(EMAN (32) and IMAGIC (33)). The class averages include
40 images/class.
RESULTS
Biophysical Characterization and Oligomeric State Determi-
nation of NDE1 and NDEL1 in Solution—Recombinant full-
length humanNDE1 and NDEL1, incorporating an N-terminal
His6 tag, were each purified from bacterial lysates using immo-
bilized metal affinity chromatography followed by size exclu-
sion chromatography. The two purifications yielded similar
size exclusion chromatograms that each featured three peaks
(Fig. 2A, referred to as P1, P2, and P3) all containing full-length
NDE1 or NDEL1, as determined by mass spectrometry. The
elution positions of these peakswere approximately similar, but
the relative abundance of each peak varied between prepara-
tions. Dynamic light scattering indicated that both P2 and P3
contained discrete oligomers of defined size (Fig. 2B), whereas
P1 consisted of highly multimeric protein. We therefore
focused on P2 and P3. In some preparations an even higher
molecular weight (MWt) peak of aggregated protein was
observed. CD revealed that, for both NDE1 and NDEL1, the
components of P2 and P3 were predominantly -helical in
composition: both exhibit near identical pronounced double
minima at 208 and 222 nm and one positive peak at 192
nm in the far-UV range, characteristic of folded proteins with
high-helical content (Fig. 2C). This agrees with previouswork
showing that -helical coiled-coils predominate in the NDEL1
N-terminal domain (5) and is consistent with CD spectra of
recombinant full-length NDEL1 (34, 35). Thermal denatur-
ation experiments on both purified protein samples recorded
melting temperatures of 47 °C, in agreement with 50 °C
reported for the N-terminal coiled-coil domain of NDEL1 (5).
Samples of P2 and P3 from both the NDE1 andNDEL1 prep-
arations (Fig. 2A) were subjected to limited chemical cross-
linking using BS3, and the resultant products were resolved
using SDS-PAGE. BS3 was used at the minimum molecular
ratio with NDE1/NDEL1 (1000:1) required to cross-link all of
the protein molecules under the conditions used. Application
of higher concentrations of BS3 up to a 2500:1 ratio did not
further alter the observed pattern of Coomassie-stained SDS-
PAGEbands seen. The pattern of bands obtained on the gels for
cross-linked NDE1 and for NDEL1 appeared very similar (Fig.
2D) with 75- and 150-kDa species detected, i.e., 2- and
4-fold larger thanmonomeric NDE1 or NDEL1 (Fig. 2D), along
with higher MWt species (250 kDa, corresponding to large
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multimers or aggregates). The size exclusion chromatograms
collected in the absence of any cross-linker suggest that P1 is
likely to correspond to the high MWt species, P2 is likely to
correspond to the tetramers, and P3 is likely to correspond to
the dimers (Fig. 2A); however, all fractions show a mixture of
these species (Fig. 2D), implying that the proteins can dynami-
cally alter their oligomeric state post elution.
Negative Stain Electron Microscopy Reveals That NDE1 and
NDEL1 Exist as Needle-like Structures and Novel Polymers in
Solution—Analysis of recombinant NDE1 and NDEL1 by neg-
ative stain EM revealed that both of these recombinant full-
length proteins form extended “needle-like” structures in solu-
tion (Fig. 3, A and B). These observations are consistent with
the tight, elongated coiled-coil crystal structure of the NDEL1
N-terminal domain (5), and they therefore extend this finding
to NDE1, in keeping with a recent study based on comparative
modeling (9). Class averages of the particle images revealed an
average width of 2–3 nm and a mode length of29 nm, with a
relatively wide distribution (Fig. 3C). The mode length is close
to what would be expected for parallel dimers (26 nm) if the
extra residues not seen in the crystal structure but predicted to
be helical (12, 36) up to amino acid position190 are included
(Figs. 1A and 3D). Some longer particles of NDE1 and NDEL1
seen by EM are consistent with the36-nm-long anti-parallel
tetramers of the N-terminal coiled-coil domains, based on pre-
vious studies (5) (see also Fig. 1). Dimers may predominate in
the EM data because of the low protein concentration used,
potentially causing disassociation of tetrameric species. Addi-
tionally, for each protein, occasional examples of longer end-
to-end linear polymers were visible (Fig. 3E), not unlike other
longer, but thicker filamentous coiled-coil proteins such as
remorins (37). These structures were still seen following treat-
ment with DNase1, implying that these are indeed NDE1/
NDEL1 and not artifacts fromDNAcontamination. C-terminal
regions either did not form compactly folded structures (in line
with predictions of high content of random coil) or were folded
but highly extended and intimately associated with the N-ter-
minal coiled-coil domain and thus could not be resolved by EM.
The NDE1 and NDEL1 C-terminal Regions Are Intimately
Associated with Their N-terminal Coiled-coil Domains—To
infer the architecture of NDE1 and NDEL1 in solution, we
deployed our previously established strategy of chemical cross-
linking followed by mass spectrometry of proteolytic frag-
ments. This methodology provides opportunities for mapping
structural details of functional complexes in solution. The
structure of proteins or protein complexes is ascertained by
identifying amino acid peptide pairs that are positioned in close
proximity to each other (21). We utilized an amine-to-amine
BS3 cross-linker that is homobifunctional, water-soluble, and
noncleavable. It contains amine-reactive N-hydroxysulfosuc-
cinimide esters that are capable of reacting with primary amine
side chain groups predominantly from Lys, but also with the
hydroxyl end groups of Ser, Thr, and Tyr at suitable pH (38).
This technique was applied to samples that had been derived
from size exclusion chromatography (Fig. 2D). Bands of cross-
linked NDE1 and NDEL1, with inferred MWts that corre-
sponded to dimeric, tetrameric, and higher MWt species, were
excised individually from the SDS-PAGE gel and subjected to
tryptic digestion. The resultant BS3-cross-linked peptides were
enriched using strong cation exchange StageTips (25). A com-
bination ofmass spectrometry and database searchingwas then
deployed to identify the cross-linked peptide pairs; these repre-
sent regions in NDE1 or in NDEL1 or between NDE1 and
NDEL1 that are in sufficiently close spatial proximity (11.4 Å
between primary amines) to interact simultaneously with the
same cross-linker. We identified a total of 300 (NDE1) and 75
(NDEL1) unambiguous linkage pairs frommass spectramatch-
ing to cross-linked peptides (supplemental Tables S1 and S2).
Example fragmentation spectra are shown in Fig. 4, whereas
cross-linked peptides detected in each oligomeric state are
shown schematically in Fig. 5 (also listed in supplemental Table
S2). A total of 64 and 23were seen in the dimeric species, 99 and
34 in the tetramer, and 137 and 18 in the highMWt species for
NDE1 and NDEL1, respectively. Some cross-linked pairs were
observed more than once (supplemental Tables S1 and S2),
adding credence to their physiological relevance in solution.
The data demonstrate that the N-terminal domain of NDE1
forms parallel dimers and that two such dimers can associate to
form tetramers, consistent with our EM data showing that
NDE1 closely resembles NDEL1 (Fig. 3). More importantly, the
data demonstrated that in both oligomeric states, the C-termi-
nal region of the protein interacts with the putative coiled-coil
FIGURE 2. Oligomeric state of recombinant NDE1 and NDEL1. A, typical
size exclusion chromatography profile of NDE1 and NDEL1 (column vol-
ume 320 ml), immediately following affinity chromatography purification
from bacterial lysate. Three peaks (P1–P3) have similar elution positions for
both proteins, but relative abundance varies. Smaller proteins were also
eluted after these peaks; however, these proteins were confirmed to be bac-
terial contaminants (and not monomeric NDE1 or NDEL1). Absorbance read-
ings were normalized after 125 ml of elution. Lowercase letters indicate the
elution volumes of protein standards: a, ferritin, 440 kDa; b, catalase, 232 kDa;
c, aldolase, 158 kDa; d, bovine serum albumin, 67 kDa; and e, ovalbumin, 44
kDa. B, mean hydrodynamic radii of P2 and P3 for each of NDE1 and NDEL1,
determinedby dynamic light scattering analysis.C, circular dichroism spectra
demonstrating that P2 of NDE1 (black) and NDEL1 (gray) share a similar, pri-
marily-helical secondary structure.D, SDS-PAGEof non-cross-linked recom-
binant NDE1 and NDEL1 (left panel) reveals monomeric species and incom-
pletely reduced dimers (all bands confirmed to represent NDE1 or NDEL1 by
mass spectrometry). In comparison, cross-linking of NDE1 and NDEL1 using
BS3 (right panel) reveals mainly dimers, tetramers, and higher MWt species.
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N-terminal domain (Fig. 5,A and B).We predict that this inter-
action would be mediated mainly by the single predicted -he-
lix (residues246–278) near the C terminus, which would be
expected to pack favorably to form an -helical bundle with the
coiled-coil domain. Note that the N- (acidic) and C-terminal
(basic) regions of NDE1 and NDEL1 have complementary the-
oretical pI values (18) that could enable favorable electrostatic
interaction. Several individual Lys residues in the C-terminal
region of both proteins were observed to each form cross-links
with multiple Lys residues in the N-terminal domain (e.g., Lys-
270 of NDE1 cross-linked to both Lys-107 and Lys-170 of
NDE1); such cross-links could not co-exist within the same
conformation. Thus, multiple conformations of the inferred
“bent back” architecture must co-exist (or undergo conforma-
tional exchange) in solution. The bend needed to explain the
cross-linking results must occur within the region linking the
FIGURE 3. Electronmicroscopy of negatively stained NDE1 and NDEL1 proteins. A, class average images of NDE1 show a long thin structure with varying
lengths that confirm the highly elongated structure predicted from sequence analysis and homology modeling (9). The C-terminal regions, predicted to be
largely unstructured (11), are not discernible in the EM data, indicating that they do not form regular stable domains. Scale bar, 20 nm. B, class average images
of NDEL1, which show very similar features. C, histogram of lengths measured from EM class average images for NDE1 (left panel) and NDEL1 (right panel).
Following alignment and classification, particle images were measuredmanually in EMAN. In10% of images the lengths were not discernible, and so these
images were excluded from the analysis. Both proteins show a mode length of29 nm, with NDEL1 showing more, longer species. Shorter species could be
the result of partial protein degradation. D, comparison of two selected NDE1 (left panels) and NDEL1 (right panels) class average images with the crystal
structures of dimeric (top panels) and tetrameric (bottom panels) NDEL1 (Protein Data Bank code 2V71) with additional predicted helical extensions (3 nm)
shown as gray boxes and drawn to scale, in each case. E, sections of rawmicrographs of NDE1 (top panels) andNDEL1 (bottompanels) show two examples each
of long filamentous polymers. The start and end positions of the polymers are indicated by black asterisks. Scale bar, 50 nm.
FIGURE 4. Example fragmentation spectra. A, fragmentation spectrum of a cross-linked peptide that includes a link between Lys-185 and Lys-170 in NDE1.
Peaks supporting QELAVQQKQEKPR are annotated in red, and those supporting LKDEAR are annotated in blue. Fragments that contain parts of both peptides
lead tomixed color annotation,where aPdenotes an intact peptide (red P represents redpeptide andblue P representsbluepeptide). Loss ofwater or ammonia
from fragments is annotated with an O in the color of the respective peptide. Unexplained peaks are shown in green. B, fragmentation spectrum of a
cross-linked peptide that includes a link between a SILAC-labeled NDE1 peptide lysine (K8) with an unlabeled but identical NDEL1 peptide lysine (Lys-170–
Lys-170), is shown. The difference in mass (doublets) is apparent for the labeled versus unlabeled lysine, even though the peptide sequences are otherwise
identical LKDEAR. Annotation and color scheme are otherwise, as shown in A.
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FIGURE 5. Structural analysis of NDE1 and NDEL1 by chemical cross-linking andmass spectrometry. NDE1 and NDEL1 are represented by blue or green
rectangular boxes, drawn to scale, running N terminus (left side) to C terminus (right side). The locations of CC R1, CC R2, and CC R3 as per the crystal structures
(5) and thepredictedC-terminal helix (CTH) (11) are shown. Pairs of residues shown tobe cross-linked together are linkedby lines. Blue dashed lines connecting
different NDE1 or NDEL1 boxes indicate cross-links that are known to be intermolecular. Red dashed lines indicate cross-links that may be intra- or intermolec-
ular.Only cross-links thatpassed thevalidationprocess aredisplayed. Someunambiguous, nonredundant cross-linkswerederived fromexperiments involving
mixedNDE1-NDEL1 samples. Details of this, and the cross-linkedpeptide pairs, can be found in supplemental Table S2. Notably, the C-terminal regions of both
NDE1andNDEL1are shown to interactwith theirN-terminal domains.Where cross-linkingdistancesmaybe inferred fromthe solvedcrystal structureofNDEL1
(ProteinData Bank code2V71) or homologymodel ofNDE1, these cross-links are shownon the respective longer fragments using cartoon representation,with
the-carbon atomsof the residues involved shownas spheres and labeled, and the closestmeasured-carbondistances (see supplemental Table S3) between
them shownby a red line. The data are shown for samples of: NDE1 dimer (A), NDE1 tetramer (B), NDEL1 dimer (C), NDEL1 tetramer (D), NDE1 highMWt species
(E), and NDEL1 high MWt species (F).
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N-terminal coiled-coil domain and the putative -helix. This
“linker” region contains eight proline residues in each of NDE1
and NDEL1 (Fig. 1A) and is predicted not to have a regular
structure. These observations are consistent with the lack of
visible density for any C-terminal domain by EM following par-
ticle averaging. The extreme C termini of subunits in dimeric
NDE1 also appear to interact with each other, as demonstrated
by cross-linking between the Lys-315 residues of two NDE1
molecules.
In the higher MWt species, similar results were obtained
except that additional cross-linking occurred between the
C-terminal region of NDE1 and another region proximal to its
N terminus; for example, Lys-270 cross-links with Lys-26 (Fig.
5). Thismay reflect the existence of the extended polymers seen
by EM, which could arise when the flexible C-terminal arms of
one NDE1 dimer (or tetramer) interact with the extreme N
terminus of another (Fig. 3E). Given their inconsistent appear-
ance and their novelty, no high resolution structural interpre-
tations can be provided at this time.
For NDEL1, the C-terminal region also bends back to inter-
act with theN-terminal coiled-coil domain (Fig. 5,C andD, and
supplemental Table S2). It is noteworthy that a previous study
that probed a NDEL1 peptide array consisting of overlapping
25-mer peptideswith full-lengthNDEL1did not find anyC-ter-
minal fragment association with the N terminus (39). In con-
trast, more recently published data indicated that a longer
47-mer peptide derived from the NDEL1 C terminus was
indeed capable of interacting with full-length NDEL1 (40). Our
data, which utilize full-length constructs, is consistent with the
latter study and provides definitive proof for this occurrence in
solution.
Mapping Cross-linking Data on the Crystal Structure Frag-
ment of NDEL1 and Homology Model of NDE1—The cross-
linked peptide pairs that originate from within the N-terminal
coiled-coil domain for the dimer and tetramer-sized bands
were analyzed with respect to the existing crystallographic data
for theN-terminal truncated fragments ofNDEL1 (amino acids
8–167 in Protein Data Bank code 2V77 and amino acids 58–168
in Protein Data Bank code 2V61) (5) and the homology-derived
models of the NDE1N-terminal fragment (9).
For the NDE1 dimer, three of the observed cross-linked pep-
tide pairs occur solelywithin the coiled-coilN-terminal domain
(amino acids 7–166) including a self-residue cross-link at Lys-
107; so these directly address the existence of this structural
motif in solution.Additionally, the aforementioned self-residue
cross-link at Lys-315 is in agreement with the inference from
the homology model of NDE1; namely that, like NDEL1, two
NDE1 chains associate unambiguously as a parallel dimer.
Within the context of the NDEL1 dimer, on the other hand,
seven pairs of cross-linked peptides were obtained within the
coiled-coil domain. Two of these, Lys-27–Lys-27 (7.8 Å,
between  carbons in 2V71) and Lys-108–Lys-108 (13.9 Å
between  carbons in 2V71), correspond to self-residue cross-
linked pairs, in further agreement with a parallel arrangement
for the coiled-coil helices in solution. Measurements in the
crystal structure for the five remaining pairs (Lys-20–Lys-27,
Lys-25–Lys-27, Lys-80–Lys-82, Ser-90–Ser-95, and Lys-108–
Tyr-114) allow distinction between feasible interchain and
intrachain cross-link formation within the NDEL1 dimer. Sup-
plemental Table S3 contains a list of the lowest calculated dis-
tances measured in three-dimensional Cartesian space for all
possible combinations of peptide residue linkages in the crystal
structures (NDEL1) and homology models (for NDE1) with
their respective oligomeric states.
With respect to the NDEL1 tetramer, seven of the cross-
linked peptide pairs reside within the coiled-coil domain. As in
the dimer, the presence of the self-residue Lys-108–Lys-108
cross-link (supplemental Tables S2 and S3) reinforces the evi-
dence for a parallel dimer. The Lys-20–Lys-27, Lys-25–Lys-27,
and Lys-80–Lys-82 cross-links that were observed in the dimer
also appear in the tetrameric sample. In addition, novel cross-
links were observed between Lys-27 and Ser-29 (5.5 Å between
 carbons in 2V71), Lys-80 and Ser-90 (15.2 Å between  car-
bons in both 2V71 and 2V66), and between Lys-108 and Lys-
113 (8.9 Å and 8.6 Å between  carbons in 2V71 and 2V66,
respectively); these cross-links are again consistent with the
crystal structure. We did not observe any cross-link that was in
conflict with the published crystal structures, i.e., greater than
themaximum theoretical distance from the cross-link of 27.4 Å
(20).
In the NDE1 tetramer, four cross-linked peptide pairs could
be identified and used for comparisons with the homology
models. Three of these, Lys-79–Lys-81, Lys-107–Lys-107, and
Lys-107–Lys-112, had previously been identified in the NDEL1
dimer and tetramer (i.e., Lys-80–Lys-82 and Lys-108–Lys-108)
and the NDEL1 tetramer (i.e., Lys-108–Lys-113), respectively.
The remaining cross-link, Lys-81–Lys-107, was novel toNDE1,
but not in agreement with the homology model. Here the 
carbon atoms are 36 Å apart from each other when mapped
onto the homologymodels (Fig. 5B), and this is addressed under
“Discussion.”
NDE1 and NDEL1 Can Co-complex in Both Parallel and
Anti-parallel Arrangements in Solution—NDE1 and NDEL1
proteins have been shown to interact with each other in mam-
malian cells (22, 41) by an unknown mechanism that is modu-
lated by a phosphorylation event that has been implicated in
neurite outgrowth (9). The two proteins are highly similar in
sequence within their respective N-terminal coiled-coils
known to facilitate tetramerization (87% identity, 99% similar-
ity, NDEL1 residues 107–192) (5); they are less similar in the
dimer-forming regions (57% identity, 87% similarity, NDEL1
residues 9–99). Based on these similarities it was hypothesized
that homodimers of NDE1 and NDEL1 might interact to form
heterotetramers (9). To test this, recombinant NDE1 and
NDEL1 in bacterial lysates weremixed together prior to co-pu-
rification (to best reflect the process by which the proteins were
purified individually) and analysis using the cross-linking, tryp-
tic digestion, and mass spectrometry strategy described above,
yielding six unambiguous cross-link pairs. Stable isotope
labeled-NDE1 was used to facilitate differentiation of NDE1
from NDEL1 peptides in some experiments, given the high
sequence conservation between the two proteins (Figs. 1A and
4B). Interestingly, cross-linked peptides were detected that
implied both parallel (Lys-107(NDE1)–Lys-108(NDEL1) and
Lys-170(NDE1)–Lys-171(NDEL1)) and anti-parallel (Ser-
196(NDE1)–Lys-108(NDEL1)) arrangements of NDE1 and
Structural Architecture of NDE1 and NDEL1 in Solution
SEPTEMBER 21, 2012•VOLUME 287•NUMBER 39 JOURNAL OF BIOLOGICAL CHEMISTRY 32389
 at Edinburgh University Library on September 20, 2013http://www.jbc.org/Downloaded from 
NDEL1 in the heterotetrameric state (Fig. 6A and supplemental
Table S2). Although the Ser-196–Lys-108 cross-link is likely,
when an anti-parallel arrangement is considered for the hetero-
tetramers (formed by two parallel homodimers that bend-back
on themselves after region 3, similar to NDE1 and NDEL1
homotetramers), the parallel arrangement could derive from a
putative heterodimeric arrangement between the two proteins
that may form. This is because the distances between the two
residues involved in the cross-link Lys-107–Lys-108 are70 Å
apart, when mapped on the modeled heterotetrameric struc-
ture that is formed by anti-parallel association between the two
proteins (Fig. 6A). Only a parallel arrangement between the two
proteins in their dimeric formation would allow for a cross-link
between the two residues in question. We subsequently pro-
cessed dimer-sized bands but did not obtain any unambiguous
cross-links between the two proteins. We conclude that NDE1
and NDEL1 are capable of interacting to form both putative
parallel heterodimers and anti-parallel heterotetramers, resem-
bling their respective homomeric counterparts. Higher molec-
ular weight species containing mixed NDE1/NDEL1 were also
observed that yielded 35 unambiguous cross-link pairs (Fig.
6B).
DISCUSSION
In this study, we demonstrated that recombinant NDE1
forms tetramers, as has previously been described for NDEL1
(5, 35). We confirmed the presence of dimeric forms of both
proteins, despite such species not being detected by Narayanan
et al. (35); this is the principal form that interacts with LIS1 (8).
We also detected higherMWt forms of the proteins in solution,
whichmay correspond to the long linear aggregates detected by
negative stain EM, and/or with larger (400 kDa) forms of
recombinant NDEL1 described previously (34). We did not,
however, find any evidence of NDE1/NDEL1 monomers, in
contrast to a previously reported 40-kDa form of NDEL1,
described as having a cysteine peptidase activity (42) and pos-
sessing40% -sheet by CD analysis. The predominantly hel-
ical, self-associating species described here and elsewhere (5,
34, 35) seems to be the physiologically relevant form of the
protein. Our results are consistent with previously published
bioinformatic analysis (11) and support the notion that a puta-
tivemonomeric coiled-coil helix would be unstable in isolation.
That some protein partners may interact preferentially with
distinct oligomeric states of NDE1 and NDEL1 (e.g., LIS1 to
dimers (8) and potentially DISC1 to tetramers (35)) raises the
intriguing possibility that the oligomeric state ofNDE1/NDEL1
may be specifically regulated within different cellular environ-
ments. Investigating this is an important avenue for future
research.
We previously undertook chemical cross-linking/MS analy-
sis on a truncated fragment of NDEL1 17–174, in an early dem-
onstration of the utility of our integrated structural analysis
toolkit (6) to shed light on the directionality of the homodi-
meric coiled-coil of NDEL1, in agreement with the crystal
structure of truncated NDEL1 (5). In this study, we extended
this analysis to the full-length constructs of NDE1, NDEL1, and
co-purified NDE1-NDEL1 to gain insight into their three-di-
mensional structural architecture. We also explored the use of
SILAC labeling to differentiate between NDE1 from NDEL1
sequences, which is the first successful application of this label-
ing approach coupled to our cross-linking/MS methodology.
We obtained, in total, 416 cross-linked peptide pairs that
could be assigned to oligomeric states of NDE1, NDEL1, and
NDE1-NDEL1 with high confidence. We showed, with addi-
tional input from EM studies, that the disordered C-terminal
regions of NDEL1 (11) have a locally flexible but overall “bent
back” architecture, presumably facilitated by the presence of
numerous proline residues in the “linker,” allowing interaction
between a strongly predicted single -helix that also resides
therein and the known N-terminal coiled-coil domain (5). Fur-
thermore, we have shown via a range of techniques that its
paralog NDE1 shares both the -helical N-terminal coiled-coil
domain, as predicted previously (9), but also the bent back
FIGURE 6. Analysis of mixed NDE1-NDEL1 by chemical cross-linking and mass spectrometry. Co-purified populations of SILAC-labeled NDE1 and unla-
beledNDEL1, aswell as co-purifiedunlabeledNDE1andunlabeledNDEL1,were analyzedusingour cross-linking/mass spectrometryparadigmas in Fig. 5.Only
those cross-linked residues confirmed to be between NDE1 and NDEL1 molecules unambiguously in the heterotetramers (A) and high MWt species (B) are
shown (purple lines in the case of SILAC-labeled NDE1-NDEL1 data and blue line for unlabeled NDE1-NDEL1 data). For the sole cross-link (Lys-107 in NDE1with
Lys-108 in NDEL1) that is present within the boundaries of the three-dimensional modeled structure of the NDE1-NDEL1 tetramer, this is shown on the
respective longer homology model fragment using cartoon representation, with the -carbon atoms of the residues involved shown as spheres and labeled,
and the -carbon distances (see supplemental Table S3) between them shown by a red line.
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C-terminal structure; thus we provide the first experimental
insights into the structure of this protein. This architecture
sheds light on how the experimentally demonstrated presence
of two dynein-interacting sites,150 amino acid residues apart
in the sequence of NDEL1, can be reconciled (18, 19). The two
binding sites are in fact brought into spatial proximity in at least
one conformation of NDEL1 (captured by cross-linking) and
most likely can contribute jointly to a common site of interac-
tion with dynein (Fig. 7). An alternative interpretation, that the
C-terminal arms of two anti-parallelNDEL1dimers (andNDE1
dimers) form a tetrameric arrangement via a continuous exten-
sion (18), cannot be formally discounted on the basis of the data
pertaining to tetrameric species. However, only our newmodel
was able to explain our cross-linking data for dimeric species of
NDE1 and NDEL1.
Interactions of NDEL1 with LIS1, Cdc42GAP, and 14-3-3
are all modulated by phosphorylation events (7, 43, 44), mainly
within the regions of the largely disordered NDEL1 C terminus
(11) (Figs. 1A and 7A). This is despite good experimental evi-
dence that these proteins bind to NDEL1 at more “structured”
sites (5, 7, 13, 18, 19, 45), distinct from the location of the phos-
phorylation sites (7, 43, 44, 46). Our observation of dynamic
interactions between N- and C-terminal domains provides an
explanation for this because it allows for the possibility that
phosphorylation in the putatively unstructured, flexible, parts
of theC-terminal region can influence the overall dynamics and
architecture of the protein sufficiently to impact on multiple
protein-protein interaction events.
The functional importance of this C-terminal region is fur-
ther highlighted by the recent identification of stop mutations
in the NDE1 gene, which result in deletion of this region (Figs.
1A and 7A). Phenotypic consequences in homozygous patients
included severe microcephaly. Likely mechanisms include the
abolition of dynein binding in these mutants, as well as the loss
of their centrosomal functions as revealed by subsequent in
vitro analysis (16, 17). These mutant proteins also displayed
reduced stability (16).We suggest that instability in the disease-
associated mutation is likely to arise, at least in part, from the
loss of the C-terminal -helix and the extra stability that it
would confer on the main coiled-coil domains of NDE1.
Another notable observation from our cross-linking studies
is that there appears to be a relative dearth of data within the
N-terminal 100 amino acid residues of NDE1 and NDEL1, the
region that facilitates dimerization (5). This is in keeping with
our previous study on NDEL1 17–174, where we only obtained
three cross-linked peptide pairs (6). This is despite subsequent
improvement inMS techniques including high resolution frag-
mentation spectra and an additional fractionation step applied
in this study. This is characteristic of the “undemocratic”
nature of the cross-linking technique (21), which requires
reactive sites of the residues in question to be available,
accessible, and in linkable geometry. In the case of NDE1 and
NDEL1, the majority of lysine residues occur from coiled-
coil region 3 onwards. These regions encompass both the
tetramerization domain of the coiled-coil (5) and the C-ter-
minal regions of the proteins, for which no structural infor-
mation was previously forthcoming.
Of the cross-linked pairs located within the N-terminal
coiled-coil region, only one in NDE1 (Lys-81–Lys-107) of a
total of 21, cannot be reconciled with either the crystal struc-
tures for N-terminal NDEL1 or the homologymodels of NDE1.
There are several possible explanations for this: (a) we utilized
full-length protein constructs, whereas the homology models
(9) were based on constructs corresponding to only the coiled-
coil domain (5); (b) we used physiological pHwhile undertaking
our cross-linking experiments, whereas the crystal structures
were solved at acidic pH (5); and (c) the coiled-coil domain
and/or the lysine side chains might be sufficiently flexible to
enable alteration in the overall structure or local environment.
Our study indicates that there are clear dynamic conforma-
tional changes for the proteins with respect to the levels of
“reach,” flexibility, and/or rigidity of the C-terminal regions
when they bend back to interactwith theN-terminal coiled-coil
domain; cross-linking can capture these dynamic structures as
we recently demonstrated (20). There exists a precedent for
dynamic change in the conformation of NDEL1 (39), the bio-
physical nature of which is unknown. Additionally, we recently
reported a protein kinase A phosphorylation site at Thr-131
within the coiled-coil region 3 in NDE1 (9). The side chains of
this residue face inwards within two opposing-helices and are
consequently not readily accessible (9). Conformations differ-
ent from those seen in crystal structures to allow this phospho-
site to be more accessible may for example ratify the single
cross-linked pair that is in conflict in the homology models.
Finally, much of the C terminus of NDE1 and NDEL1 is pre-
dicted to lack a fixed structure (11), consistent with the notion
that the C terminus might bend back in multiple ways.
Our circular dichroism, electronmicroscopy, and cross-link-
ing data demonstrate that NDE1 and NDEL1 share a highly
similar overall structure, reinforcing the suggestion that they
FIGURE 7.Abentbackmodel forNDEL1andNDE1and its implications for
dynein interaction. A, a linear cartoon of NDEL1 showing the locations of its
two known dynein-binding domains (gray dashed lines), located more than
150 amino acids apart in the primary structure (18, 19, 45). The known LIS1
interaction domain is also shown (5, 7, 8). The N-terminal coiled-coil domain
and predicted C-terminal helix are displayed, as in Fig. 1. Asterisks indicate
known phosphorylation sites in NDE1 (black) (9, 11) and NDEL1 (gray) (7, 10,
12). Dashed black lines indicate C-terminal regions deleted by two frameshift
mutations that cause severe microcephaly (16, 17). The N and C termini are
indicated. B, our “bent back” model of the NDE1/NDEL1 dimer C terminus
brings the two dynein-binding domains into close physical proximity.
C, hypothetical model of the NDE1/NDEL1 tetramer; note that it is unclear
whether all four C-terminal regions can “bend back” simultaneously or how
they interact with each other. This has the potential, however, to bringmany
dynein-binding domains from the different chains into close proximity with
each other.
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fulfill similar roles in the cell (47), known to include neurite
outgrowth and mitotic functions (reviewed in Refs. 3 and 4),
although the possibility that they are differentially regulated, in
terms of expression, post-translational modification or pro-
tein-protein interaction partners, remains. The question of
whether NDE1 andNDEL1 perform these roles in parallel or in
partnership is less clear. Previously, it was determined that
NDE1 and NDEL1 can be co-immunoprecipitated from both
cell lines and brain lysates, although a direct interaction
between them had not been shown (22, 41), leaving it unclear
whether they form functional heteromultimers or simply inter-
act simultaneously with common binding proteins such as
DISC1 or LIS1. Here we demonstrate that such direct binding
of NDE1 and NDEL1 can occur, at least at the level of hetero-
tetramer formation and higher molecular weight species. Fur-
thermore, it appears that the mechanisms by which NDE1 and
NDEL1 interact with each other include those by which they
each form homo-oligomers. Future work to dissect how differ-
ential phosphorylation of these two proteins functions syner-
gistically to influence the overall architecture of the hetero-
oligomers is now needed.
Finally, our results bear upon possible pathogenic mecha-
nisms.Not onlywillmutations inNDE1 reported inmicroceph-
aly abrogate function, but they are also likely to influence
NDEL1 interaction (we obtained a cross-link between NDEL1
108 and NDE1 296 in the heterotetramer), DISC1 binding, and
other associated protein interaction pathways. Similarly, copy
number variation for NDE1 has also been reported in associa-
tion with both autism (48) and schizophrenia (49–54). That
NDE1 and NDEL1 are shown by our analysis to form hetero-
oligomers suggests that this propensity will be affected by the
balance of NDE1 and NDEL1 expression that may be altered in
disease-associated gene insertions or deletions.
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